Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
9421
-
9422
ßNGF expression.
Published 2015“…When mast cells are activated, their granule content is released outside the cell, thus the immunostaining for the marker progressively decreases within the cell. Magnification bars, <b>A</b> to <b>E</b>: 50 μm; <b>F</b> to <b>I</b>: 10 μm. …”
-
9423
Untargeted Urinary Proteomics Uncovers Nephroprotective and Systemic Adaptations after Obesity Surgery-Induced Weight Loss
Published 2025“…A decrease in inflammation protein markers (α-1-acid glycoproteins), alongside an increase in proteins associated with immune modulation and oxidative stress protection (dipeptidase 1, heat shock cognate 71 kDa protein) were observed. …”
-
9424
-
9425
-
9426
-
9427
Change in Adverse Events After Enrollment in the National Surgical Quality Improvement Program: A Systematic Review and Meta-Analysis
Published 2016“…Studies evaluating other adverse events noted decreased incidence following NSQIP participation and implementation of a formal quality improvement program.…”
-
9428
DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting
Published 2017“…</p><p>Conclusion</p><p>The introduction of SAT during the continuation phase of RR-TB treatment does not adversely affect final RR-TB treatment outcomes in a high TB and HIV-burden setting. This differentiated, patient-centred model of care could be considered in RR-TB programmes to decrease the burden of DOT on patients and health facilities.…”
-
9429
-
9430
-
9431
-
9432
A Novel Function for Kojic Acid, a Secondary Metabolite from <i>Aspergillus</i> Fungi, as Antileishmanial Agent
Published 2014“…KA (50 μg/mL) was found to decrease the growth by 62% (IC<sub>50</sub> 34 μg/mL) and 79% (IC<sub>50</sub> 27.84 μg/mL) of promastigotes and amastigotes <i>in vitro</i>, respectively. …”
-
9433
-
9434
-
9435
Table_1_Immunotherapy With Recombinant Alt a 1 Suppresses Allergic Asthma and Influences T Follicular Cells and Regulatory B Cells in Mice.docx
Published 2021“…</p>Methods<p>We synthesized and purified rAlt a 1. Alternaria-sensitized and challenged mice received subcutaneous immunotherapy (SCIT) with four different rAlt a 1 dosages (5, 50, 100, and 150 µg) or PBS only. …”
-
9436
Image_1_Immunotherapy With Recombinant Alt a 1 Suppresses Allergic Asthma and Influences T Follicular Cells and Regulatory B Cells in Mice.tif
Published 2021“…</p>Methods<p>We synthesized and purified rAlt a 1. Alternaria-sensitized and challenged mice received subcutaneous immunotherapy (SCIT) with four different rAlt a 1 dosages (5, 50, 100, and 150 µg) or PBS only. …”
-
9437
Image_2_Immunotherapy With Recombinant Alt a 1 Suppresses Allergic Asthma and Influences T Follicular Cells and Regulatory B Cells in Mice.tif
Published 2021“…</p>Methods<p>We synthesized and purified rAlt a 1. Alternaria-sensitized and challenged mice received subcutaneous immunotherapy (SCIT) with four different rAlt a 1 dosages (5, 50, 100, and 150 µg) or PBS only. …”
-
9438
Proper Notch signaling is required for the differentiation of <i>agr2</i><sup><i>+</i></sup> epidermal mucous cells and <i>pvalb8</i>-positive cells.
Published 2021“…<b>(C).</b> Substantial decreases in <i>agr2</i><sup><i>+</i></sup> EMC numbers in the trunks and yolks were detected in embryos treated with 50 μM of MK0752 from 10–14 hpf or 11–15 hpf but not from 10–13 hpf or 11–14 hpf, as compared to respective DMSO-treated embryos during 10–14 hpf or 11–15 hpf. …”
-
9439
-
9440